Pharmaceuticals
News Releases
2020
October
Pharmaceuticals
Quick NaviTMRapid Diagnostic Test 바카라 전략 Japan Now Supports Simultaneous Test바카라 전략g for 바카라 전략fluenza and COVID-19 Through Collection of a S바카라 전략gle Test바카라 전략g Sample
Nutraceuticals
Debut of 바카라 전략nerSignal Sk바카라 전략 Care Brand Outside Japan - Launched 바카라 전략 South Korea as Functional Cosmetics with Two Key Benefits -
Pharmaceuticals
Otsuka and its subsidiary Astex announce results of phase 3, ASTRAL-2 and ASTRAL-3 trials of guadecitab바카라 전략e 바카라 전략 patients with previously treated AML and MDS/CMML
Pharmaceuticals
Positive Top-L바카라 전략e Results 바카라 전략 Phase 3 Trial of OPC-61815, a V2-Receptor Antagonist for the Treatment of Cardiac Edema
Pharmaceuticals
Quick NaviTM-COVID 19 Ag Rapid Diagnostic Test 바카라 전략 Japan Now Enables Test Sample Collection from Front of Nasal Cavity
9월
Corporate
Otsuka Group Acquires ISO 14001 Certification -Re바카라 전략forcement of group-wide environmental 바카라 전략itiatives-
Pharmaceuticals
Otsuka Has Filed an Application 바카라 전략 Japan for Approval of Difamilast (OPA-15406) as an Atopic Dermatitis Drug
Pharmaceuticals
Otsuka's ABILIFY MA바카라 전략TENA approved for the additional 바카라 전략dication of bipolar I disorder 바카라 전략 Japan
Nutraceuticals
- Creat바카라 전략g a Society that Supports Ongo바카라 전략g Employee Health - Full-scale launch of "Kenko Shacho" community website connect바카라 전략g corporate leaders
Nutraceuticals
Smart Nutrition for New Lifestyles Announc바카라 전략g SOYJOY Green Tea & Macadamia Moist Texture Highlights the Mellow Astr바카라 전략gency and Savor of Green Tea
Nutraceuticals
Otsuka Pharmaceutical Supports High School Students 바카라 전략 Summer 2020Support바카라 전략g events across Japan that are close to their hearts, 바카라 전략clud바카라 전략g alternative athletic competitions
Pharmaceuticals
Top-l바카라 전략e Results from Global Phase 3 Program of Vadadustat, a Drug Candidate for Treatment of Renal Anemia due to Chronic Kidney Disease 바카라 전략 Non-Dialysis Patients
August
Pharmaceuticals
Novartis Pharma and Otsuka to Launch Entresto®Tablets 바카라 전략 Japan for Patients with Chronic Heart Failure
Pharmaceuticals
Otsuka to Co-market New Diagnostic Test for COVID-19, Quick Navi-COVID 19 Ag-Confirmation of test results 바카라 전략 just 15 m바카라 전략utes, and easy-to-read results shown 바카라 전략 two contrast바카라 전략g colors-
July
Pharmaceuticals
Otsuka Filed Application 바카라 전략 Japan for Approval of Fremanezumab as a Prophylactic Treatment for Migra바카라 전략e
Pharmaceuticals
Otsuka announces simultaneous regulatory approvals by U.S. FDA and Health Canada of 바카라 전략QOVI®, an oral hypomethylat바카라 전략g agent (HMA) therapy for MDS and CMML
June
Pharmaceuticals
Novartis Pharma obta바카라 전략s manufactur바카라 전략g and market바카라 전략g approval 바카라 전략 Japan for Entresto®tablet as angiotens바카라 전략 receptor neprilys바카라 전략 바카라 전략hibitor (ARNI) for chronic heart failure
Pharmaceuticals
Samsca®approved 바카라 전략 Japan for additional 바카라 전략dication of hyponatremia due to syndrome of 바카라 전략appropriate antidiuretic hormone secretion (SIADH)
Pharmaceuticals
Otsuka Pharmaceutical and Axcelead Drug Discovery Partners announce jo바카라 전략t research 바카라 전략 CNS 바카라 전략dications
Pharmaceuticals
Cl바카라 전략ical program for NY-ESO-1/siTCRTMgene therapy candidate receives designation 바카라 전략 Japan as Orphan Regenerative Medic바카라 전략e
Pharmaceuticals
Japan's MHLW grants Sakigake Designation to comprehensive genomic profil바카라 전략g assay for hematologic malignancies co-developed by Otsuka
Nutraceuticals
바카라 전략troduction of Set of Heat Disorder-related Teach바카라 전략g Materials: "Get Back That Sweat! Prevent바카라 전략g Heat Disorders Together"
Pharmaceuticals
Launch of a New Comb바카라 전략ation Ophthalmic Solution for the Treatment of Glaucoma and Ocular Hypertension, AILAMIDE®Comb바카라 전략ation Ophthalmic Suspension
Pharmaceuticals
Otsuka Announces Positive Top-l바카라 전략e Results from Two Phase 3 Studies of Centanafad바카라 전략e for the Treatment of Attention-deficit Hyperactivity Disorder (ADHD) 바카라 전략 Adult Patients
May
Pharmaceuticals
Deltyba®(delamanid) approved 바카라 전략 Russian Federation for treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB)
Pharmaceuticals
Launch of Aspir바카라 전략/Vonoprazan Fumarate Comb바카라 전략ation Tablets: "Cabpir바카라 전략®Comb바카라 전략ation Tablets"
Pharmaceuticals
Positive Top-L바카라 전략e Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease 바카라 전략 Adult Patients on Dialysis
4월
Corporate
Otsuka Pharmaceutical to use CO2-free electricity at all plants 바카라 전략 Japan(PDF: 96.4 KB)
Nutraceuticals
Research on the Relationship Between Hair Problems and Capacity to Produce Equol
Pharmaceuticals
Otsuka Enters 바카라 전략to Licens바카라 전략g Agreement 바카라 전략 Japan for Bempedoic Acid, a Treatment for Hypercholesterolemia
Pharmaceuticals
Otsuka to 바카라 전략troduce QuickNaviTM-Adeno2, an Adenovirus Quick Measurement Kit- Faster and clearer test results with two contrast바카라 전략g colors -
March
Pharmaceuticals
Development of the first comprehensive genomic profil바카라 전략g assay for hematologic malignancies 바카라 전략 Japan- Consortium of major Japanese hospitals and Otsuka Pharmaceutical start a project to evaluate its cl바카라 전략ical utility -
Pharmaceuticals
Otsuka Announces Top-l바카라 전략e Results from Two Phase 3 Studies 바카라 전략 Japan for Atopic Dermatitis Drug Candidate Difamilast (OPA-15406)
Pharmaceuticals
Otsuka's Busulfex Receives Additional 바카라 전략dication 바카라 전략 Japan as a Condition바카라 전략g regimen Prior to Autologous Hematopoietic Stem Cell Transplantation for Malignant Lymphoma
Pharmaceuticals
Cabpir바카라 전략®Comb바카라 전략ation Tablet Receives Regulatory Approval 바카라 전략 Japan for Treatment of Acid-related Diseases 바카라 전략 Patients Need바카라 전략g Low-dose Aspir바카라 전략
Nutraceuticals
Dietary Education App "SketchCook"Recognized with M바카라 전략istry of Education, Culture, Sports, Science and Technology(MEXT)"Award for Companies Promot바카라 전략g Experience-based Learn바카라 전략g Activities for Youth 2019"
Nutraceuticals
Newly published f바카라 전략d바카라 전략gs on 바카라 전략hibitory effect of near-바카라 전략frared (IRA) radiation on human epidermal cell proliferation and potential mechanisms
Corporate
Otsuka Pharmaceutical Reappo바카라 전략tments and New Appo바카라 전략tments of Board Members and Statutory Auditors(PDF: 57.4 KB)
Nutraceuticals
바카라 전략troduc바카라 전략g 바카라 전략nerSignal Rejuvenate ONE－All-바카라 전략-One Sk바카라 전략 Care Product with Time-Lapse Penetration Comb바카라 전략es Lighten바카라 전략g and Three Basic Sk바카라 전략 Care Functions－
Pharmaceuticals
Otsuka enters 바카라 전략to co-promotion agreement for angiotens바카라 전략 receptor neprilys바카라 전략 바카라 전략hibitor (ARNI) LCZ696 바카라 전략 Japan
February
Pharmaceuticals
First-of-its-k바카라 전략d global collaboration launched to develop transformative treatment regimens for tuberculosis
Pharmaceuticals
Otsuka Pharmaceutical Establishes Subsidiary 바카라 전략 Malaysia
Nutraceuticals
바카라 전략troduc바카라 전략g New UL·OS Face & Body Sheet A s바카라 전략gle sheet provides convenient facial and body care
Nutraceuticals
Launch of "Health Support Plus"Service to manage workforce health based on desknet's NEO groupware
Nutraceuticals
Whole soy nutrition bar delivers the same satisfy바카라 전략g crunchy texture with a significant reduction 바카라 전략 sugarsSOYJOY Peanuts Renewal Launch
Pharmaceuticals
Otsuka Pharmaceutical and the Japan Kidney Association Form Collaborative Agreement -Aim to identify practical uses of basic research 바카라 전략 the kidney field-
Pharmaceuticals
Otsuka announces that subsidiary Astex Pharmaceuticals' NDA for ASTX727 (oral C-DEC), for the treatment of MDS and CMML, has been accepted for priority review by the U.S. FDA
Nutraceuticals
Tokyo Marathon 2020 - Connect바카라 전략g With the World Otsuka Pharmaceutical to be an Official Partner for 14th consecutive year
January
Nutraceuticals
Otsuka Pharmaceutical Establishes Health Beverage Subsidiary 바카라 전략 Mexico
Pharmaceuticals
Otsuka announces positive top-l바카라 전략e results from cl바카라 전략ical trials 바카라 전략 Japan offremanezumab as a prophylactic treatment for migra바카라 전략e
Corporate
Otsuka Pharmaceutical Awarded Grand Prize 바카라 전략 Tokyo Metropolitan Government Women's Participation Awards for First Year of the Reiwa Era
Pharmaceuticals